Efficacy and tolerability of zonisamide versus controlled-release carbamazepine for newly diagnosed partial epilepsy: a phase 3, randomised, double-blind, non-inferiority trial.
Lancet Neurol. 2012 Jul; 11(7):579-88
Tracy Glauser
07 Sep 2012
|
Clinical Trial
This interesting randomized double blind non-inferiority comparative trial demonstrated that zonisamide was non-inferior to controlled release carbamazepine in adults with newly diagnosed partial epilepsy. This trial is one of the few clinical trials conducted according to the 2006 International League against Epilepsy (ILAE) guidelines...
INDIVIDUAL SUBSCRIPTIONS
Get instant access to Article Recommendations from more than 5,000 expert scientists and clinical researchers, assisted by 5,000 associates, by taking out a monthly subscription. The first month of your subscription will be free of charge.
Start your personal subscription today.
Subscribe for $9.95/monthINSTITUTIONAL SUBSCRIPTIONS
Send a recommendation to your institution's librarian or information manager to request an extended free trial for all users.
Recommend to your LibrarianIf you are a librarian or information manager, you may request an extended free trial for your academic or corporate institution.
Request an Institutional Trialyour institution might be eligible for free access via our sponsorship scheme. Check our sponsorship page.
If you think you should be able to access this content, please contact us.